Preparatory Mindset
The "Big Three" adult mental disorders — depression, anxiety, PTSD — are the focus of this chapter (CM exam tested). The lecture (10 Depression anxiety PTSD, 5.6KB) covers DSM-5 criteria, subtypes, and treatment. The exam tests: DSM-5 Mood & Anxiety disorders criteria, PTSD criteria, the cognitive triad of depression, anxiety disorder types, and the multimodal treatment approach (medication + psychotherapy).
Exam mindset: know the DSM-5 depression criteria (≥5 of 9 symptoms for ≥2 weeks including depressed mood or anhedonia), anxiety disorder taxonomy (GAD, panic, social anxiety, specific phobia), and PTSD criteria (trauma + re-experiencing + avoidance + arousal + ≥1 month).
Core Concepts
1. Depression (MUST KNOW)
- Definition: people with depression experience persistent feelings of sadness and hopelessness and lose interest in activities they once enjoyed
- Somatic symptom: chronic pain, digestive issues
- To be diagnosed: symptoms must be present for at least 2 weeks
2. DSM-5 Major Depressive Disorder (MUST KNOW — 9 symptoms, ≥5, ≥2 weeks, must include #1 or #2)
- Depressed mood most of the day, nearly every day
- Markedly diminished interest or pleasure (anhedonia) in all, or almost all, activities
- Significant weight loss when not dieting or weight gain
- A slowing down of thought and a reduction of physical movement (psychomotor retardation)
- Fatigue or loss of energy nearly every day
- Feelings of worthlessness or excessive or inappropriate guilt
- Diminished ability to think or concentrate, or indecisiveness
- Recurrent thoughts of death, suicidal ideation, or suicide attempt
- Insomnia or hypersomnia
- Mnemonic: SIG-E-CAPS — Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor, Suicide
- Subtypes: melancholic, atypical, psychotic, seasonal (winter — SAD), peripartum
- Bipolar disorder: alternating mania/hypomania with depression (Bipolar I = mania; Bipolar II = hypomania)
3. Anxiety disorders (MUST KNOW)
- Generalized Anxiety Disorder (GAD): excessive worry about multiple things for ≥6 months; restlessness, fatigue, difficulty concentrating, muscle tension, sleep disturbance - Panic Disorder: recurrent panic attacks (sudden onset of intense fear, peak in minutes); 4+ symptoms (palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, derealization, fear of dying, paresthesia); anticipatory anxiety leads to agoraphobia (fear of places where escape is difficult) - Social Anxiety Disorder (Social Phobia): fear of social scrutiny → anxiety, blushing, avoidance - Specific Phobia: fear of a specific object/situation (animals, heights, blood) - Agoraphobia: fear of places where escape is difficult (open spaces, crowds, public transport) - Separation Anxiety Disorder, Selective Mutism - Substance/Medication-induced anxiety disorder
- Definition: a type of mental health condition where people respond to certain things/situations with fear and dread; physical signs (pounding heart, sweating)
- Types (DSM-5):
4. Anxiety symptoms (4 categories)
- Cardiovascular: palpitations, tachycardia, chest pain
- Respiratory: shortness of breath, hyperventilation
- GI: nausea, abdominal pain, diarrhea
- Neurological: tremor, dizziness, paresthesia, derealization
- Cognitive: fear of losing control, fear of dying
5. PTSD (Posttraumatic Stress Disorder) (MUST KNOW)
- Intrusion (re-experiencing): flashbacks, nightmares, intrusive thoughts, distress on exposure to cues - Avoidance: of thoughts, feelings, people, places associated with the trauma - Negative alterations in cognition & mood: guilt, shame, distorted beliefs, emotional numbness, dissociation - Hyperarousal: sleep disturbances, irritability, hypervigilance, startle response, concentration difficulty
- Trauma exposure: actual/threatened death, serious injury, or sexual violence (combat, assault, accident, disaster)
- DSM-5 criteria (≥1 month):
- Acute stress disorder: <1 month
- Complex PTSD: prolonged trauma + emotional dysregulation, interpersonal difficulties (in ICD-11)
- Risk factors: severity, prior trauma, female sex, low SES, lack of support
- Comorbidities: depression, substance use, suicide risk
6. Etiology / biopsychosocial model
- Biological: genetic predisposition, neurotransmitter dysregulation (serotonin, norepinephrine, dopamine, GABA, glutamate), HPA axis dysregulation, structural brain changes (amygdala, hippocampus, prefrontal cortex)
- Psychological: early adversity, negative cognition (Beck's cognitive triad), learned helplessness (Seligman)
- Social: stressful life events, chronic stress, lack of support, trauma
7. Treatment (MUST KNOW)
- Pharmacotherapy: SSRIs (first-line, e.g., sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), TCAs (imipramine, amitriptyline — cardiac toxicity in overdose), MAOIs (rare, dietary restrictions) - Psychotherapy: CBT (most evidence-based), IPT (interpersonal therapy), behavioral activation, MBCT (relapse prevention), psychodynamic, & for severe depression: ECT (electroconvulsive therapy) - TMS (transcranial magnetic stimulation), ketamine (treatment-resistant) - Suicide risk assessment: ideation, plan, means, timing, protective factors
- Pharmacotherapy: SSRIs/SNRIs (first-line for long-term), benzodiazepines (short-term, risk of dependence), buspirone, pregabalin - Psychotherapy: CBT (exposure, cognitive restructuring), exposure therapy (systematic desensitization), relaxation, mindfulness
- Trauma-focused CBT (TF-CBT), EMDR (eye movement desensitization and reprocessing), prolonged exposure (PE), cognitive processing therapy (CPT), narrative exposure therapy - SSRIs (sertraline, paroxetine — FDA-approved for PTSD) - Brief eclectic psychotherapy, group therapy
- Depression:
- Anxiety:
- PTSD:
8. Cognitive triad of depression (Beck)
- Negative view of self ("I am inadequate")
- Negative view of the world ("The world is hostile")
- Negative view of the future ("Things will never get better")
- Treatment: identify and dispute these distorted thoughts
9. Suicidal patient (MUST KNOW)
- Risk assessment: SI (ideation), plan, means, intent, timing, prior attempt; protective factors: reasons for living, support, religion/spirituality
- SAFE: S — Specify the plan; A — Available means; F — Frequency of thoughts; E — Escape plan
- Intervention: remove means, hospitalize if needed, start SSRI, therapy, follow-up, family involvement
High-Yield Points
- Depression: ≥5 of 9 symptoms for ≥2 weeks including depressed mood or anhedonia (Mnemonic: SIG-E-CAPS)
- Anxiety types: GAD (6 months), panic (4+ symptoms + agoraphobia), social anxiety, specific phobia, agoraphobia
- PTSD criteria: trauma + intrusion + avoidance + negative cognitions + hyperarousal (≥1 month)
- First-line pharmacotherapy: SSRIs (depression, anxiety, PTSD)
- Benzodiazepines: short-term for anxiety; tolerance & dependence risk
- CBT: evidence-based for depression, anxiety, PTSD
- Beck's cognitive triad: negative self, world, future
- Suicide risk: SI, plan, means, intent, prior attempt; remove means
- ECT: for severe/treatment-resistant depression
- EMDR & trauma-focused CBT: for PTSD
- Anxiety symptoms: 4 categories (cardiovascular, respiratory, GI, neurological)
Topic Summary
Depression (DSM-5 Major Depressive Disorder) requires ≥5 of 9 symptoms for ≥2 weeks, including depressed mood or anhedonia (mnemonic: SIG-E-CAPS — Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor, Suicide). Anxiety disorders include GAD (≥6 months of excessive worry), Panic Disorder (recurrent panic attacks with 4+ symptoms ± agoraphobia), Social Anxiety Disorder, specific phobias, and agoraphobia. PTSD follows exposure to trauma with ≥1 month of intrusive re-experiencing, avoidance, negative cognitions/mood, and hyperarousal. Etiology is biopsychosocial — biological (genetic, serotonin/norepinephrine/GABA dysregulation, HPA axis), psychological (Beck's cognitive triad, learned helplessness), social (stress, trauma, lack of support). Treatment: SSRIs are first-line for depression, anxiety, and PTSD; CBT is the most evidence-based psychotherapy; anxiety also uses benzodiazepines (short-term) and exposure therapy; PTSD also uses EMDR, prolonged exposure, and cognitive processing therapy (CM exam tested). Suicidal patients need safety planning (remove means, hospitalization), risk assessment, and ongoing follow-up.
LMCHK OSCE Practice
- Recognize depression: screen with PHQ-9; ask about sleep, interest, energy, guilt, concentration, appetite, suicidality.
- Beck's cognitive triad: identify the patient's negative self/world/future views; introduce cognitive restructuring.
- Anxiety disorder differentiation: use the Mini-International Neuropsychiatric Interview (MINI) or SCARED/self-report scales.
- PTSD screening: for the patient with a history of trauma — use the PCL-5; assess hyperarousal, intrusive memories, avoidance.
- CBT psychoeducation: explain the cognitive model — thoughts, feelings, behaviors, physiology interconnect; changing one changes the others.
- Behavioral activation for depression: schedule pleasurable activities (the depressed patient lacks motivation — re-engage with rewarded activities).
- Suicide risk assessment: SAFE approach — ask SPECIFICALLY about plan, means, intent; do NOT be afraid to ask (asking does not increase risk).
- Crisis intervention: imminent suicide risk → remove means, hospitalize (involuntary if needed), start SSRI, family, follow-up within 24h.
- Exposure hierarchy for phobia: establish the hierarchy (least to most feared) and practice relaxation + exposure.
- PTSD: trauma-focused CBT: the gold standard — exposure + cognitive restructuring; EMDR is an alternative.
- SSRI counseling: explain the 4-6 week onset, side effects (GI, sexual, sleep), tapering (not sudden), and adherence.